Health

Donanemab, an investigational drug for treating early Alzheimer’s disease, has recently received unanimous support from an FDA advisory committee. The committee’s 11-0 vote affirmed that the benefits of donanemab outweigh its risks for Alzheimer’s patients with mild cognitive impairment and mild dementia enrolled in clinical trials. Furthermore, the committee agreed that available data demonstrated the
0 Comments
Physicians like Anthony Fauci and Jason Liebowitz are facing unique challenges in their respective fields of expertise. The pressure is evident when Rep. Jamie Raskin mentions that he is not a comic book super-villain, highlighting the immense scrutiny and expectations placed on healthcare professionals. Meanwhile, Jason Liebowitz’s statement about being replaceable sheds light on the
0 Comments
The SYNERGY-NASH phase II study demonstrated the efficacy of tirzepatide in resolving metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. The trial conducted by Dr. Rohit Loomba involved 190 participants with biopsy-confirmed MASH and fibrosis. The results indicated a significant resolution of MASH without worsening of fibrosis in patients treated with tirzepatide compared to those in
0 Comments
Greek authorities are currently on the lookout for Michael Mosley, MD, a renowned British weight-loss doctor and television personality who mysteriously disappeared while vacationing on the picturesque island of Symi. This news has sparked concerns among the medical community and his followers. Disturbing reports have emerged regarding the spread of bird flu among cows in
0 Comments
A study conducted at the University of Oklahoma College of Medicine in Oklahoma City, revealed that the use of transvenous phrenic nerve stimulation (TPNS) was associated with a five-fold increase in the likelihood of improved clinical outcomes for patients suffering from central sleep apnea and heart failure. This study, which analyzed the results of the
0 Comments
Recently, a group of passengers on a flight to Houston who had returned from an international cruise experienced sudden illness midair. The cause of this unknown illness has yet to be determined, leaving many concerned about the potential health risks associated with air travel. Dr. Anthony Fauci is set to testify before Congress in a
0 Comments
A recent interim analysis of the phase III ECHELON-3 trial has showcased the potential benefits of a triplet combination for patients with diffuse large B-cell lymphoma (DLBCL). The combination of brentuximab vedotin (BV), lenalidomide, and rituximab outperformed the standard lenalidomide-rituximab regimen in terms of overall survival (OS). Patients who received the triplet experienced a median
0 Comments